Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia

<h4>Background</h4> <p>Classic galactosemia is a rare genetic metabolic disease with an unmet treatment need. Current standard of care fails to prevent chronically-debilitating brain and gonadal complications.</p> <br/> <p>Many mutations in the GALT gene responsi...

Full description

Bibliographic Details
Main Authors: Haskovic, M, Derks, B, Van Der Ploeg, L, Trommelen, J, Nyakayiru, J, Van Loon, L, Mackinnon, S, Yue, W, Peake, R, Zha, L, Demirbas, D, Qi, W, Huang, X, Berry, G, Achten, J, Bierau, J, Rubio-Gozalbo, M, Coelho, A
Format: Journal article
Language:English
Published: BioMed Central 2018
_version_ 1797067904252903424
author Haskovic, M
Derks, B
Van Der Ploeg, L
Trommelen, J
Nyakayiru, J
Van Loon, L
Mackinnon, S
Yue, W
Peake, R
Zha, L
Demirbas, D
Qi, W
Huang, X
Berry, G
Achten, J
Bierau, J
Rubio-Gozalbo, M
Coelho, A
author_facet Haskovic, M
Derks, B
Van Der Ploeg, L
Trommelen, J
Nyakayiru, J
Van Loon, L
Mackinnon, S
Yue, W
Peake, R
Zha, L
Demirbas, D
Qi, W
Huang, X
Berry, G
Achten, J
Bierau, J
Rubio-Gozalbo, M
Coelho, A
author_sort Haskovic, M
collection OXFORD
description <h4>Background</h4> <p>Classic galactosemia is a rare genetic metabolic disease with an unmet treatment need. Current standard of care fails to prevent chronically-debilitating brain and gonadal complications.</p> <br/> <p>Many mutations in the GALT gene responsible for classic galactosemia have been described to give rise to variants with conformational abnormalities. This pathogenic mechanism is highly amenable to a therapeutic strategy based on chemical/pharmacological chaperones. Arginine, a chemical chaperone, has shown beneficial effect in other inherited metabolic disorders, as well as in a prokaryotic model of classic galactosemia.</p> <br/> <p>The p.Q188R mutation presents a high prevalence in the Caucasian population, making it a very clinically relevant mutation. This mutation gives rise to a protein with lower conformational stability and lower catalytic activity. The aim of this study is to assess the potential therapeutic role of arginine for this mutation.</p> <h4>Methods</h4> <p>Arginine aspartate administration to four patients with the p.Q188R/p.Q188R mutation, in vitro studies with three fibroblast cell lines derived from classic galactosemia patients as well as recombinant protein experiments were used to evaluate the effect of arginine in galactose metabolism. This study has been registered at https://clinicaltrials.gov (NCT03580122) on 09 July 2018. Retrospectively registered.</p> <h4>Results</h4> <p>Following a month of arginine administration, patients did not show a significant improvement of whole-body galactose oxidative capacity (p = 0.22), erythrocyte GALT activity (p = 0.87), urinary galactose (p = 0.52) and urinary galactitol levels (p =0.41). Patients’ fibroblasts exposed to arginine did not show changes in GALT activity. Thermal shift analysis of recombinant p.Q188R GALT protein in the presence of arginine did not exhibit a positive effect.</p> <h4>Conclusions</h4> <p>This short pilot study in four patients homozygous for the p.Q188R/p.Q188R mutation reveals that arginine has no potential therapeutic role for galactosemia patients homozygous for the p.Q188R mutation.</p>
first_indexed 2024-03-06T22:03:05Z
format Journal article
id oxford-uuid:4f44f3f2-92d0-4835-bb8f-e083515b6115
institution University of Oxford
language English
last_indexed 2024-03-06T22:03:05Z
publishDate 2018
publisher BioMed Central
record_format dspace
spelling oxford-uuid:4f44f3f2-92d0-4835-bb8f-e083515b61152022-03-26T16:06:04ZArginine does not rescue p.Q188R mutation deleterious effect in classic galactosemiaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4f44f3f2-92d0-4835-bb8f-e083515b6115EnglishSymplectic Elements at OxfordBioMed Central2018Haskovic, MDerks, BVan Der Ploeg, LTrommelen, JNyakayiru, JVan Loon, LMackinnon, SYue, WPeake, RZha, LDemirbas, DQi, WHuang, XBerry, GAchten, JBierau, JRubio-Gozalbo, MCoelho, A <h4>Background</h4> <p>Classic galactosemia is a rare genetic metabolic disease with an unmet treatment need. Current standard of care fails to prevent chronically-debilitating brain and gonadal complications.</p> <br/> <p>Many mutations in the GALT gene responsible for classic galactosemia have been described to give rise to variants with conformational abnormalities. This pathogenic mechanism is highly amenable to a therapeutic strategy based on chemical/pharmacological chaperones. Arginine, a chemical chaperone, has shown beneficial effect in other inherited metabolic disorders, as well as in a prokaryotic model of classic galactosemia.</p> <br/> <p>The p.Q188R mutation presents a high prevalence in the Caucasian population, making it a very clinically relevant mutation. This mutation gives rise to a protein with lower conformational stability and lower catalytic activity. The aim of this study is to assess the potential therapeutic role of arginine for this mutation.</p> <h4>Methods</h4> <p>Arginine aspartate administration to four patients with the p.Q188R/p.Q188R mutation, in vitro studies with three fibroblast cell lines derived from classic galactosemia patients as well as recombinant protein experiments were used to evaluate the effect of arginine in galactose metabolism. This study has been registered at https://clinicaltrials.gov (NCT03580122) on 09 July 2018. Retrospectively registered.</p> <h4>Results</h4> <p>Following a month of arginine administration, patients did not show a significant improvement of whole-body galactose oxidative capacity (p = 0.22), erythrocyte GALT activity (p = 0.87), urinary galactose (p = 0.52) and urinary galactitol levels (p =0.41). Patients’ fibroblasts exposed to arginine did not show changes in GALT activity. Thermal shift analysis of recombinant p.Q188R GALT protein in the presence of arginine did not exhibit a positive effect.</p> <h4>Conclusions</h4> <p>This short pilot study in four patients homozygous for the p.Q188R/p.Q188R mutation reveals that arginine has no potential therapeutic role for galactosemia patients homozygous for the p.Q188R mutation.</p>
spellingShingle Haskovic, M
Derks, B
Van Der Ploeg, L
Trommelen, J
Nyakayiru, J
Van Loon, L
Mackinnon, S
Yue, W
Peake, R
Zha, L
Demirbas, D
Qi, W
Huang, X
Berry, G
Achten, J
Bierau, J
Rubio-Gozalbo, M
Coelho, A
Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia
title Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia
title_full Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia
title_fullStr Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia
title_full_unstemmed Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia
title_short Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia
title_sort arginine does not rescue p q188r mutation deleterious effect in classic galactosemia
work_keys_str_mv AT haskovicm argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia
AT derksb argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia
AT vanderploegl argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia
AT trommelenj argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia
AT nyakayiruj argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia
AT vanloonl argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia
AT mackinnons argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia
AT yuew argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia
AT peaker argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia
AT zhal argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia
AT demirbasd argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia
AT qiw argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia
AT huangx argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia
AT berryg argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia
AT achtenj argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia
AT bierauj argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia
AT rubiogozalbom argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia
AT coelhoa argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia